Mirum Pharmaceuticals, Inc.
MIRM
$44.32
-$0.075-0.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -77.34M | -87.94M | -99.81M | -109.16M | -158.56M |
| Total Depreciation and Amortization | 25.37M | 24.98M | 24.20M | 20.59M | 15.78M |
| Total Amortization of Deferred Charges | 1.68M | 1.66M | 1.64M | 1.63M | 1.53M |
| Total Other Non-Cash Items | 53.88M | 46.82M | 53.71M | 53.46M | 96.95M |
| Change in Net Operating Assets | -10.44M | 24.80M | 19.04M | 10.06M | 7.35M |
| Cash from Operations | -6.85M | 10.33M | -1.23M | -23.43M | -36.96M |
| Capital Expenditure | -1.02M | -993.00K | -973.00K | -792.00K | -81.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | -212.76M | -212.76M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -105.23M | -89.13M | -91.79M | -43.94M | 78.62M |
| Cash from Investing | -106.25M | -90.13M | -92.77M | -257.49M | -134.23M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 305.30M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22.85M | 17.70M | 14.42M | 217.68M | 212.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -281.00K | -281.00K | -192.98M |
| Cash from Financing | 22.85M | 17.70M | 14.14M | 217.40M | 324.82M |
| Foreign Exchange rate Adjustments | -355.00K | -1.30M | 190.00K | -213.00K | -208.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -90.60M | -63.40M | -79.67M | -63.73M | 153.42M |